Suchergebnisse - "Brooks, William"

PubPharm (2)

1

Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation : A randomized control trial

enthalten in: Brain, behavior, and immunity | 2024

von Weickert, T. | Jacomb, I. | Lenroot, R. | +14

2

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease

enthalten in: Nature medicine | 2021

von Salloway, S. | Farlow, M. | McDade, E. | +67

1
[1]